We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 1.32% | 3.85 | 3.70 | 4.00 | 3.85 | 3.80 | 3.80 | 132,766 | 08:04:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 3.19M | -6.49M | -0.0122 | -3.11 | 20.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/11/2024 12:48 | Smith keeping it tight and brief on Ecovelex 2025. There is a reason for that.... The Vikings are coming. 🌽🌻 | supersonico | |
08/11/2024 12:20 | A really good informative interview this one - | money never sleeps | |
08/11/2024 11:08 | hxxps://genius.com/T | money never sleeps | |
08/11/2024 10:40 | Alchemy, So Cavendish has a target of 20p and Eden say's in their opinion the shares are worth north of 20p. This is as of today. It doesn't take account of a full Ecovelex approval, an insecticide partner(s) and a Powdery Mildew approval in France for Esseva delivering up to 10* greater revenue than Mevalone treating Botrytis. It all adds up to a bargain share price of currently, 3.7p. So for those following the story, it offers a time to accumulate where desired and reassurance for those that are tapped out. To remind us, Ecovelex is a €33.8 million opportunity. As the Trading Update RNS stated yesterday, "However, the opportunity for the insecticide product could well surpass anything else we have done to date, and this is exciting for all of us." In other words, in my opinion, financial numbers stated in Eden presentations are likely understated. No cash needed! Question: What will Cavendish's price target be when these RNS's are delivered (expected soon according to Eden) and what will managements view of share price be at that stage? 3.7p is a ridiculous opportunity to invest in Eden with three triggers so close. | investingisatrickygame | |
08/11/2024 06:56 | Viking watch.🐦 .............㊔ 'To make it possible for us to perceive and to comprehend things invisible, we are forced to conceptualize objects whose existence cannot be independently verified but can only be inferred from their observable influences similarly to the way physicists infer the existence of subatomic particles. ' Orlov 2024 🌽🌻 No Sightings today but the 'outlook' commentary of 'EU-wide approval of Ecovelex' on it's timetable 2025+ 'Very soon' anticipated arrival was noted. 🌽🌻 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 💰 | supersonico | |
07/11/2024 22:12 | Second Ecovelex 2024 Approval announced ~6 weeks earlier than 2023. Full EU🧑 .................... Eden Research and Corteva Agriscience Announce Ecovelex?2023 Approval in Italy Cremona, Italy and Abingdon, UK - December 18, 2023 - Corteva Agriscience and Eden Research are pleased to announce that Ecovelex? 2023 has been granted, according to Reg. EU/1107/2009, a temporary approval in Italy for use as a bird repellent seed treatment in corn for the 2024 growing season. Eden is an AIM listed company that develops and supplies sustainable solutions for crop protection, animal health and consumer products. ............. Ecovelex Approval in Italy 07 November 2024 Eden Research plc ("Eden") is pleased to announce that Ecovelex™ 2024 has been granted, according to Reg. EU/1107/2009, approval in Italy for use as a bird repellent seed treatment in corn for the 2025 growing season. Eden is a leader in sustainable biopesticide and biocontrol products and technologies. | supersonico | |
07/11/2024 21:38 | 🧑 | supersonico | |
07/11/2024 19:00 | Many thanks | alchemy | |
07/11/2024 18:54 | Alchemy Just before 59 minutes | investingisatrickygame | |
07/11/2024 18:00 | Absolutely want to see that FD view but can't find it. Could you kindly point it out. It would change my day!Does he indicate why? | alchemy | |
07/11/2024 16:20 | MNS Home and Garden is on slide 10 of the most recent presentation (2024 interims) and I assume is not as high in revenue potential as the three mentioned today Cedroz is approved in the US ( Today's trading update mentions what we understand to be the three biggest pending revenue opportunities for Eden, insecticide, Ecovelex and Esseva in France for Powdery Mildew Once these 3 are approved it seems to me that the FD's value of Eden declared at 'north of 20p' today will be somewhat enhanced and that in my opinion is where we should look for the share price to be. | investingisatrickygame | |
07/11/2024 15:06 | OK, lets try again; So lets make the Bio-stimulant question more precise. What Bio-stimulant product will Humair Tariq be promoting? Humair Tariq Bio-Controls I Bio-Stimulants | Agriculture | Global Commercial | Sales & Marketing Will Syngenta be Eden's partners..they seem to appreciate Bio-stimulants; Syngenta Biologicals 🌱 The Biostimulants World Congress is just around the corner and we’re gearing up for insightful discussions that will address some of the most pressing challenges in agriculture today. On November 13, Jacqui Campbell will join a panel discussion to explore new technologies in agriculture focusing on current technologies, products, growth opportunities, and identifying possible gaps in the market. The conversation continues on November 14 as Marco Rosso delves into the role of biostimulants in regenerative agriculture, and we will find out the Farmer’s Award winner! | supersonico | |
07/11/2024 15:06 | So we have got the Italian news which if I recall means we can put some deliveries there into 24 figures. But we are missing Broker's estimate by .8 million. I'm struggling to find a reason for this RNS excep to say we need more time. The positives are in place but longer to appear.It's similar in structure to lord give me chastity but not yet. | alchemy | |
07/11/2024 14:29 | Ask them yourself. | kittybiscuits | |
07/11/2024 14:27 | So, waiting to hear from you geniuses exactly why the directors don't buy shares in this sookerstuck, and between the lot of them hold barely 1%. Should I hold my breath, losers? :D | neutralpov | |
07/11/2024 12:27 | Bully for him, the guy is a genius but I didn’t actually say he didn’t. | kittybiscuits | |
07/11/2024 12:01 | God Neuts, what a cowardly coward you are. Have a good day. TbS. | timbo_slice | |
07/11/2024 11:59 | @KB ... Rav was a profitable investor in EDEN. Not something I can say. | timbo_slice | |
07/11/2024 11:08 | Products whose existence cannot be independently verified but can only be inferred from notable observable influences..news; The Syngenta Bio stimulant seed treatment wild guess as suggested by the Bio change of our new fella Humair; AWGATWT. From Humair Tariq Results & Data-Driven Marketing Expert | Global Portfolio Management @ Syngenta I Catapulting Businesses to New Heights | Unmatched NPI Prowess I Mastering Digital Capabilities I Entrepreneur I Founder@Barbell Studioz St Ives to Humair Tariq (He/Him) Bio-Controls I Bio-Stimulants | Agriculture | Global Commercial | Sales & Marketing | supersonico | |
07/11/2024 10:00 | You are a long term holder, therefore must be special. | ravenna23 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions